期刊
PHYTOTHERAPY RESEARCH
卷 35, 期 9, 页码 4913-4929出版社
WILEY
DOI: 10.1002/ptr.7121
关键词
anticancer; cell signalling pathways; curcumin; matrix metalloproteins; NF‐ κ B
资金
- Portuguese Foundation for Science and Technology under the Horizon 2020 [PTDC/PSI-GER/28076/2017]
- Fundação para a Ciência e a Tecnologia [PTDC/PSI-GER/28076/2017] Funding Source: FCT
Cancer is the second-leading cause of death worldwide, and while effective treatments are available, they often come with severe side effects. Researchers are now focusing on finding anticancer therapies with minimal side effects, with phytochemicals such as curcumin gaining attention as potential options.
Cancer is the second-leading cause of death worldwide. Till date, many such effective treatments are available, for example chemotherapy, surgery, and radiation therapy, but there are severe associated side effects, such as increased infection risk, constipation, hair loss, anaemia, among others. Thus, the need for effective therapeutic strategies and screening methodology arises. Researchers around the world are increasingly trying to discover anticancer therapies with as few side effects as possible and many are now focusing on phytochemicals, like curcumin. Curcumin is a bright yellow substance isolated from the plant rhizomes of Curcuma longa L. To this molecule a high therapeutic benefit has been underlined, being able to alter the development of cancer by different mechanisms, such as regulating multiple microRNA expression, modifying a series of signalling pathways, that is, Akt, Bcl-2, PTEN, p53, Notch, and Erbb. Another major pathway that curcumin targets is the matrix metalloproteinase (MMP) gene expression. In fact, MMPs are responsible for the degradation of the cell-extracellular matrix, which can lead to the diseased condition and many different pathways contribute to its activity, such as JAK/STAT, NF-kappa B, MAPK/ERK, COX-2, ROS, TGF-beta, among others. In this review, we have attempted to describe the curcumin regulatory effect on different cell signalling pathways involved in the progression of different types of cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据